骨质疏松骨代谢生化指标的研究进展

[1] 基质金属蛋白酶-1、-2与女性年龄、骨转换生化指标及骨密度的关系 [J]. 中华内科杂志, 2006, (04) : 306 - 309

[2] 护骨素及配体在卵巢切除大鼠骨组织的蛋白表达和细胞定位 [J]. 中国骨质疏松杂志, 2005, (04) : 37 - 40

[3] 血清骨特异性酸性磷酸酶的临床意义 [J]. 中华内分泌代谢杂志, 2003, (06) : 48 - 49

[4] 原发性骨质疏松症防治的进展和趋势 [J]. 老年医学与保健, 2003, (02) : 67 - 68

[5] 老年人骨折与骨密度及骨代谢生化测定探讨 [J]. 中国老年学杂志, 2002, (03) : 190 - 191

[6] Bone biology and the pathogenesis of osteoporosis[J] . R Graham G Russell,Belen Espina,Philippa Hulley.Current Opinion in Rheumatology . 2006

[7] Undercarboxylated osteocalcin concentration in postmenopausal women receiving hormone therapy daily and on alternate days [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2006, 13 (02): : 314 - 322

[8] Inhibition of RANKL as a treatment for osteoporosis: Preclinical and early clinical studies[J] . Michael R. McClung.Current Osteoporosis Reports . 2006 (1)

[9] The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans [J]. CLINICAL ENDOCRINOLOGY, 2006, 64 (06) : 689 - 697

[10] Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis[J] . Jun Iwamoto,Tsuyoshi Takeda,Yoshihiro Sato,Mitsuyoshi Uzawa.Clinical Rheumatology . 2007 (2)

[1] 基质金属蛋白酶-1、-2与女性年龄、骨转换生化指标及骨密度的关系 [J]. 中华内科杂志, 2006, (04) : 306 - 309

[2] 护骨素及配体在卵巢切除大鼠骨组织的蛋白表达和细胞定位 [J]. 中国骨质疏松杂志, 2005, (04) : 37 - 40

[3] 血清骨特异性酸性磷酸酶的临床意义 [J]. 中华内分泌代谢杂志, 2003, (06) : 48 - 49

[4] 原发性骨质疏松症防治的进展和趋势 [J]. 老年医学与保健, 2003, (02) : 67 - 68

[5] 老年人骨折与骨密度及骨代谢生化测定探讨 [J]. 中国老年学杂志, 2002, (03) : 190 - 191

[6] Bone biology and the pathogenesis of osteoporosis[J] . R Graham G Russell,Belen Espina,Philippa Hulley.Current Opinion in Rheumatology . 2006

[7] Undercarboxylated osteocalcin concentration in postmenopausal women receiving hormone therapy daily and on alternate days [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2006, 13 (02): : 314 - 322

[8] Inhibition of RANKL as a treatment for osteoporosis: Preclinical and early clinical studies[J] . Michael R. McClung.Current Osteoporosis Reports . 2006 (1)

[9] The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans [J]. CLINICAL ENDOCRINOLOGY, 2006, 64 (06) : 689 - 697

[10] Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis[J] . Jun Iwamoto,Tsuyoshi Takeda,Yoshihiro Sato,Mitsuyoshi Uzawa.Clinical Rheumatology . 2007 (2)